|
|
|
Volumn 25, Issue 11, 1998, Pages 2053-2055
|
|
The ethics of anticytokine therapy for rheumatoid arthritis: Editorial
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
CYTOKINE;
CYTOKINE INHIBITOR;
DNA ANTIBODY;
INTERLEUKIN 1;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
ANTIBODY PRODUCTION;
CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
EDITORIAL;
HUMAN;
MEDICAL ETHICS;
OUTCOMES RESEARCH;
PATIENT SELECTION;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SYSTEMIC LUPUS ERYTHEMATOSUS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
ARTHRITIS, RHEUMATOID;
CYTOKINES;
HUMANS;
|
|
EID: 0031791749
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (3)
|
|
References (30)
|
